ALLISON ZERN: Open Payments
NPI 1821632506 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 16 payments from 12 companies in 2025. Trend: 2023 $429 · 2024 $348 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Antares Pharma, Inc. | 2 | $30 |
| Boston Scientific Corporation | 1 | $25 |
| Medtronic, Inc. | 1 | $24 |
| Davol Inc. | 1 | $20 |
| TOLMAR, INC. | 1 | $19 |
| Becton, Dickinson and Company | 1 | $18 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $18 |
Products named: GEMTESA, KEYTRUDA, BOTOX, XYOSTED, Bulkamid, CREON, DEXTILE, ARISTA.
Industry payments across IL — which companies pay providers there.
